pfizer canada responds - understanding biologic and biosimilar treatments
Published 5 years ago • 511 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
0:47
biosimilars video series: the decision to transition from an original biologic to a biosimilar
-
1:01
biosimilars video series: differences and similarities between biologics and biosimilars
-
2:21
what are biosimilars?
-
0:53
biosimilars video series: transition to a biosimilar
-
2:52
what's health canada saying about biosimilars?
-
3:00
biosimilars: complex copycat drugs
-
3:15
what is a biologic?
-
11:49
how do monoclonal antibodies work? rituximab, infliximab, adalimumab and others
-
1:58
transitioning to a biosimilar the patient journey
-
1:34
pfizer canada gives a hand
-
57:41
webinar: biologics & biosimilars
-
1:18
the rise of biosimilars in canadian healthcare
-
1:01:08
oc replay biologics & biosimilars – an overview for healthcare providers
-
2:21
switching from a biologic to a biosimilar drug in canada
-
2:47
biosimilars: approval process
-
1:30
biologics and biosimilars: increasing treatment options
-
3:02
biosimilar medications — what patients need to know
-
11:29
all you need to know about biologics - how they work, when to use them and the common side effects
-
1:20
how to differentiate between a biologic, generic, and biosimilar drug
-
4:09
better understanding biosimilar medications
-
4:42
biosimilars vs. biologics: side effects, safety and effectiveness
-
11:15
pricing of biosimilars with biologics and other biosimilars